Share-based Payment Arrangement, Expense of Gritstone bio, Inc. from 31 Dec 2016 to 30 Jun 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Gritstone bio, Inc. quarterly and annual Share-based Payment Arrangement, Expense in USD history and change rate from 31 Dec 2016 to 30 Jun 2024.
  • Gritstone bio, Inc. Share-based Payment Arrangement, Expense for the quarter ending 30 Jun 2024 was $3,467,000, a 18% increase year-over-year.
  • Gritstone bio, Inc. Share-based Payment Arrangement, Expense for the twelve months ending 30 Jun 2024 was $12,500,000, a 5% increase year-over-year.
  • Gritstone bio, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $11,618,000, a 7.5% decline from 2022.
  • Gritstone bio, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $12,557,000, a 19% increase from 2021.
  • Gritstone bio, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $10,552,000, a 48% increase from 2020.
Source SEC data
View on sec.gov
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Change (%)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Change (%)

Gritstone bio, Inc. Quarterly Share-based Payment Arrangement, Expense (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q2 2024 $12,500,000 $3,467,000 +$527,000 +18% 01 Apr 2024 30 Jun 2024 10-Q 13 Aug 2024 2024 Q2
Q1 2024 $11,973,000 $3,246,000 +$355,000 +12% 01 Jan 2024 31 Mar 2024 10-Q 09 May 2024 2024 Q1
Q4 2023 $11,618,000 $2,823,000 -$185,000 -6.2% 01 Oct 2023 31 Dec 2023 10-K 05 Mar 2024 2023 FY
Q3 2023 $11,803,000 $2,964,000 -$100,000 -3.3% 01 Jul 2023 30 Sep 2023 10-Q 08 Nov 2023 2023 Q3
Q2 2023 $11,903,000 $2,940,000 -$414,000 -12% 01 Apr 2023 30 Jun 2023 10-Q 13 Aug 2024 2024 Q2
Q1 2023 $12,317,000 $2,891,000 -$240,000 -7.7% 01 Jan 2023 31 Mar 2023 10-Q 09 May 2024 2024 Q1
Q4 2022 $12,557,000 $3,008,000 +$209,000 +7.5% 01 Oct 2022 31 Dec 2022 10-K 05 Mar 2024 2023 FY
Q3 2022 $12,348,000 $3,064,000 +$245,000 +8.7% 01 Jul 2022 30 Sep 2022 10-Q 08 Nov 2023 2023 Q3
Q2 2022 $12,103,000 $3,354,000 +$621,000 +23% 01 Apr 2022 30 Jun 2022 10-Q 09 Aug 2023 2023 Q2
Q1 2022 $11,482,000 $3,131,000 +$930,000 +42% 01 Jan 2022 31 Mar 2022 10-Q 11 May 2023 2023 Q1
Q4 2021 $10,552,000 $2,799,000 +$1,102,000 +65% 01 Oct 2021 31 Dec 2021 10-K 05 Mar 2024 2023 FY
Q3 2021 $9,450,000 $2,819,000 +$982,000 +53% 01 Jul 2021 30 Sep 2021 10-Q 03 Nov 2022 2022 Q3
Q2 2021 $8,468,000 $2,733,000 +$776,000 +40% 01 Apr 2021 30 Jun 2021 10-Q 04 Aug 2022 2022 Q2
Q1 2021 $7,692,000 $2,201,000 +$582,000 +36% 01 Jan 2021 31 Mar 2021 10-Q 05 May 2022 2022 Q1
Q4 2020 $7,110,000 $1,697,000 +$254,000 +18% 01 Oct 2020 31 Dec 2020 10-K 09 Mar 2023 2022 FY
Q3 2020 $6,856,000 $1,837,000 +$305,000 +20% 01 Jul 2020 30 Sep 2020 10-Q 03 Nov 2021 2021 Q3
Q2 2020 $6,551,000 $1,957,000 +$640,000 +49% 01 Apr 2020 30 Jun 2020 10-Q 05 Aug 2021 2021 Q2
Q1 2020 $5,911,000 $1,619,000 +$612,000 +61% 01 Jan 2020 31 Mar 2020 10-Q 06 May 2021 2021 Q1
Q4 2019 $5,299,000 $1,443,000 +$160,000 +12% 01 Oct 2019 31 Dec 2019 10-K 10 Mar 2022 2021 FY
Q3 2019 $5,139,000 $1,532,000 +$993,000 +184% 01 Jul 2019 30 Sep 2019 10-Q 05 Nov 2020 2020 Q3
Q2 2019 $4,146,000 $1,317,000 +$498,000 +61% 01 Apr 2019 30 Jun 2019 10-Q 05 Aug 2020 2020 Q2
Q1 2019 $3,648,000 $1,007,000 +$653,000 +184% 01 Jan 2019 31 Mar 2019 10-Q 07 May 2020 2020 Q1
Q4 2018 $2,995,000 $1,283,000 01 Oct 2018 31 Dec 2018 10-K 11 Mar 2021 2020 FY
Q3 2018 $539,000 +$234,000 +77% 01 Jul 2018 30 Sep 2018 10-Q 12 Nov 2019 2019 Q3
Q2 2018 $819,000 01 Apr 2018 30 Jun 2018 10-Q 12 Aug 2019 2019 Q2
Q1 2018 $354,000 01 Jan 2018 31 Mar 2018 10-Q 13 May 2019 2019 Q1
Q3 2017 $305,000 01 Jul 2017 30 Sep 2017 10-Q 14 Nov 2018 2018 Q3

Gritstone bio, Inc. Annual Share-based Payment Arrangement, Expense (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2023 $11,618,000 -$939,000 -7.5% 01 Jan 2023 31 Dec 2023 10-K 05 Mar 2024 2023 FY
2022 $12,557,000 +$2,005,000 +19% 01 Jan 2022 31 Dec 2022 10-K 05 Mar 2024 2023 FY
2021 $10,552,000 +$3,442,000 +48% 01 Jan 2021 31 Dec 2021 10-K 05 Mar 2024 2023 FY
2020 $7,110,000 +$1,811,000 +34% 01 Jan 2020 31 Dec 2020 10-K 09 Mar 2023 2022 FY
2019 $5,299,000 +$2,304,000 +77% 01 Jan 2019 31 Dec 2019 10-K 10 Mar 2022 2021 FY
2018 $2,995,000 +$1,869,000 +166% 01 Jan 2018 31 Dec 2018 10-K 11 Mar 2021 2020 FY
2017 $1,126,000 +$529,000 +89% 01 Jan 2017 31 Dec 2017 10-K 11 Mar 2020 2019 FY
2016 $597,000 01 Jan 2016 31 Dec 2016 10-K 28 Mar 2019 2018 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.